Abbott Again Goes After Sandoz Over Generic Zemplar
Abbott Laboratories on Friday renewed its efforts to protect its Zemplar kidney disease drug, launching a lawsuit in Delaware federal court in which Sandoz Inc. is once again accused of infringing...To view the full article, register now.
Already a subscriber? Click here to view full article